Keywords
How to Cite
Abstract
Adenoid enlargement (AE) is a common issue in children, frequently resulting in nasal blockage, snoring, oral breathing, and repeated ear infections. Although adenoidectomy continues to be the primary solution for severe instances, medical treatment has surfaced as a feasible option. This research investigates the efficiency of using Montelukast, a leukotriene receptor blocker, alongside intranasal Mometasone furoate, a corticosteroid, in contrast to single-drug treatment. Clinical results were determined by evaluating symptoms, examining the nasopharynx, and using endoscopic observation. The combined treatment provided better symptom alleviation and decreased adenoid tissue compared to each medication alone, with few side effects. The results indicate that combination therapy could be a safe and effective non-surgical option for children experiencing adenoid hypertrophy.
References
1. Ahmed AF, El-Banhawy OA, El-Anwar MW. Effect of topical mometasone furoate on adenoidal lymphoid tissue: A light microscopic study. J Laryngol Otol. 2015;129(6):563–569.
2. Alanazi AM, Alshahrani MA, Alzahrani FM, et al. Efficacy of montelukast and intranasal corticosteroids in pediatric adenoid hypertrophy: A systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2024;281(3):1121–1133.
3. Bitar MA, et al. Adenoid hypertrophy in children: Etiology and management. Int J Pediatr Otorhinolaryngol. 2014;78(9):1519–1523.
4. Brodsky L. Modern assessment of tonsils and adenoids. Pediatr Clin North Am. 1989;36(6):1551–1569.
5. Demirhan H, Aksoy F, Yıldırım YS, et al. Medical treatment of adenoid hypertrophy with intranasal steroids and leukotriene receptor antagonists. Int J Pediatr Otorhinolaryngol. 2010;74(7):773–776.
6. Elshafey MM, Khalil HS, Abdel-Aal KM. Effect of montelukast combined with intranasal mometasone furoate on adenoid hypertrophy in children. Am J Otolaryngol. 2020;41(5):102571.
7. Gozal D, Kheirandish-Gozal L. Sleep-disordered breathing in children. Lancet Respir Med. 2013;1(1):41–51.
8. Kheirandish-Gozal L, Goldbart AD, Gozal D. Intranasal steroids and oral leukotriene modifier therapy in residual sleep-disordered breathing after adenotonsillectomy in children. Pediatrics. 2006;117(1):e61–e66.
9. Kim J, et al. Combined therapy in adenoid hypertrophy. Pediatr Pulmonol. 2015;50(7):696–702.
10. Kousha T, et al. Effect of montelukast on adenoid hypertrophy in children. Int J Pediatr Otorhinolaryngol. 2013;77(12):1971–1975.
11. Meltzer EO, et al. Intranasal corticosteroids in pediatric patients. Ann Allergy Asthma Immunol. 2009;103(5):383–392.
12. Shokouhi F, Sayyahfar S, Jalessi M, et al. Montelukast in the treatment of adenoid hypertrophy in children: A randomized controlled trial. Iran J Otorhinolaryngol. 2015;27(80):357–363
13. Wu S, Chen X, Li Y, et al. Facial development in children with chronic nasal obstruction. J Craniofac Surg. 2016;27(1):183–187.
This work is licensed under a Creative Commons Attribution 4.0 International License.